|
|
|
| Why the Superbugs Are Winning |
 |
|
By Betsy McCaughey
Wednesday, May 24 2017 |
The deadliest superbug yet—Candida auris—is invading hospitals and nursing homes, killing a staggering 60 percent of patients it infects. Some exposed patients don't succumb to infection but silently carry the germ and infect others. So far, the lethal germ has sickened patients in New York, New Jersey, Michigan, Illinois and Massachusetts, with 122 cases reported so far this year, up from only six last year. The germ—a fungus—lingers on bedrails and on the uniforms and hands of doctors and nurses, ready to attack the next patient. Once it gets inside a catheter or breathing device and invades a patient's body, it kills. Candida auris is already in 15 hospitals in New York, including prestigious medical centers. Acting CDC Director Anne Schuchat calls it a "catastrophic threat." Strong words, but don't expect health authorities to do much. They're saying what they always say—patients dying from these infections were already seriously ill. Well, duh. Who else goes to a hospital? Health care infections—from Candida auris and many other germs—kill at least 75,000 hospital patients a year and five times that number in nursing homes. That's nearly half a million deaths a year. Politicians talk nonstop about insurance guaranteeing seriously ill people access to care. But the biggest risk to these patients isn't lack of insurance. It's infection. Infections jeopardize vulnerable patients' access to organ transplants, cancer therapy and HIV/AIDS treatments, even if they have insurance. New York City is ground zero, with three-quarters of the cases. But the state's health commissioner Howard Zucker claims Candida auris "poses no risk to the general public" because it "impacts patients who are already ill for other reasons." Why write them off? Watching officials downplay Candida auris is deja vu all over again. In 1999, researchers revealed the existence of a killer germ CRE (short for carbapenem-resistant bacteria) at Downstate Medical Center in Brooklyn. But state health officials and the CDC failed to act. By 2008, the germ had reached 22 states, often carried by patients from New York. In 2011, a woman with CRE transferred from a New York hospital to the National Institutes of Health in Maryland, which set off an outbreak that killed 11 patients there, including a 16-year-old boy. Not until 2013 did health officials label carbapenem-resistant germs "nightmare bacteria" and call for "urgent and aggressive action." Tough words but no follow-up. Now CRE is in hospitals and nursing homes nationwide. Yet the CDC is dithering instead of insisting all hospitals screen patients likely to have the germ so precautions can be taken to stop its spread. And Medicare doesn't reimburse for screening, though it's a necessary tool. Compare this needless dying to Israel's resolve when CRE reached its borders in 2007. Health authorities launched a screen and clean campaign, reducing CRE by 70 percent in one year, and followed up with a four-year campaign to slash CRE's presence in nursing homes. In Israel patients—even newborns—are routinely screened to prevent the germ from spreading. Meanwhile health officials in the U.S. cater to the hospital and nursing home industries and excuse shoddy infection control. Despite protests from members of Congress, the CDC sticks with outdated guidelines for how to clean patients' rooms, ignoring the potential of automatic room disinfection to save lives. Similarly, Medicare officials turn a blind eye to hospitals filing false infection rate reports, a new Inspector General report says. Until public health officials start fighting for patients, the superbugs will keep winning. ---------------------------------------------------------------------------------------------------------------------------------------- Betsy McCaughey is chairman of the Committee to Reduce Infection Deaths. |
Related Articles : |
